ASX:PMEHealthcare Services
Pro Medicus (ASX:PME): How US Contract Momentum Shapes Its Current Valuation
Pro Medicus (ASX:PME) has made headlines by clinching three major US hospital contracts in just four months. This achievement has already tripled its contract win rate from last year and sparked fresh curiosity among investors.
See our latest analysis for Pro Medicus.
Despite some recent share price volatility, including a 10.98% dip over the past month, Pro Medicus is still up 24.96% on a total shareholder return basis for the past year and has delivered a remarkable 336% over three years...